SLCO1A2 and metabolic dysfunction-associated steatohepatitis: Animal observations can add another possible contributing factor, which is a decreased Oatp1 levels in the kidney shown in the animal NASH model of liver dysfunction, and thus reduced capacity of Oatp1 substrate renal excretion [61].